David F Bibby
Overview
Explore the profile of David F Bibby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mbisa J, Kirwan P, Tostevin A, Ledesma J, Bibby D, Brown A, et al.
Clin Infect Dis
. 2018 Dec;
69(7):1136-1143.
PMID: 30534981
Background: Drug-resistant minority variants (DRMinVs) detected in patients who recently acquired human immunodeficiency virus type 1 (HIV-1) can be transmitted, generated de novo through virus replication, or technical errors. The...
12.
Afshar B, Bibby D, Piorkowska R, Ohemeng-Kumi N, Snoeck R, Andrei G, et al.
J Clin Virol
. 2017 Oct;
96:89-93.
PMID: 29031157
Background: Herpes Simplex Virus (HSV) drug resistance is a significant public health concern among immunocompromised individuals. Phenotypic assays are considered the gold standard method for detecting HSV drug resistance. However,...
13.
Manso C, Bibby D, Mbisa J
Sci Rep
. 2017 Jun;
7(1):4173.
PMID: 28646219
RNA viruses cause significant human pathology and are responsible for the majority of emerging zoonoses. Mainstream diagnostic assays are challenged by their intrinsic diversity, leading to false negatives and incomplete...
14.
Cunningham E, Chan Y, Aghaizu A, Bibby D, Murphy G, Tosswill J, et al.
J Antimicrob Chemother
. 2016 Oct;
72(1):227-234.
PMID: 27742812
Objectives: To determine the prevalence of inferred low-frequency HIV-1 transmitted drug resistance (TDR) in MSM in the UK and its predicted effect on first-line therapy. Methods: The HIV-1 pol gene...
15.
Groves K, Bibby D, Clark D, Isaksen A, Deayton J, Anderson J, et al.
J Acquir Immune Defic Syndr
. 2012 Aug;
61(4):407-16.
PMID: 22902723
Background: The mechanism of CD4 T-cell decline in HIV-1 infection is unclear, but the association with plasma viral RNA load suggests viral replication is involved. Indeed, viremic controller patients with...
16.
Johnson G, Bibby D, Wong S, Agrawal S, Bustin S
PLoS One
. 2012 Jul;
7(7):e40022.
PMID: 22808087
The polymerase chain reaction (PCR) is widely used as a diagnostic tool in clinical laboratories and is particularly effective for detecting and identifying infectious agents for which routine culture and...
17.
Comparative evaluation of the Seegene Seeplex RV15 and real-time PCR for respiratory virus detection
Bibby D, McElarney I, Breuer J, Clark D
J Med Virol
. 2011 Jun;
83(8):1469-75.
PMID: 21678451
Respiratory virus infections contribute substantially both to hospitalizations of young children, and to morbidity in immunocompromised patients such as those with hematological malignancies. Their rapid and accurate diagnosis is essential...
18.
Sarfo F, Bibby D, Schwab U, Appiah L, Clark D, Collini P, et al.
J Antimicrob Chemother
. 2009 Jun;
64(3):667-9.
PMID: 19549668
No abstract available.
19.
Bibby D, Gill A, Kirby L, Farquhar C, Bruce M, Garson J
J Virol Methods
. 2008 Apr;
151(1):107-15.
PMID: 18433888
Clinical diagnosis and research into transmissible spongiform encephalopathies are hampered by the lack of sufficiently sensitive and specific reagents able to adequately detect the normal cellular form of the prion...
20.
Jalal H, Bibby D, Bennett J, Sampson R, Brink N, Mackinnon S, et al.
J Clin Microbiol
. 2007 Mar;
45(6):1690-6.
PMID: 17392447
A large simultaneous outbreak of respiratory syncytial virus (RSV) and parainfluenza type 3 (PIV-3) infections occurred on an adult hematology unit. Implementation of enhanced infection control was complicated by cocirculation...